Please use a minimum of three unique search wordsOur search is configured to only display links relevant to answer your question. For the best results please use specific and relevant keywords that accurately reflect the information you are seeking.Please do not use this field to report adverse events or product complaints. Adverse events and product complaints should be reported. Reporting forms and information can be found at UK: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on 01256 315 000.
ZypAdhera ® (olanzapine pamoate monohydrate)
ZypAdhera® (olanzapine pamoate): Gluten
The solvent contains pharmaceutical grade highly purified mannitol that is obtained from either corn or wheat starch.
The active ingredient of ZypAdhera is olanzapine pamoate.1
The excipients are:1
Water for injections
Hydrochloric acid (for pH adjustment)
Sodium hydroxide (for pH adjustment)
ZypAdhera is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients of ZypAdhera.1
1. ZypAdhera [summary of product characteristics] Eli Lilly Netherland B.V., The Netherlands.
Date of Last Review: February 13, 2020